Sanquin Blood Supply Foundation
Sanquin Blood Supply Foundation is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 5 of 5 trials · Latest update first
A Phase 3, Multicenter, Randomized, Double-Blind Study of the Efficacy and Safety of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (The ReSPECT Study)
Sponsor Mundipharma Research Limited
- Start (EU)
- Latest update
- Estimated end
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia
Sponsor Universitair Medisch Centrum Utrecht
- Start (EU)
- Latest update
- Estimated end
- Not reported
HOVON 165 CLL: A prospective randomized phase I/II trial of venetoclax treatment (26 cycles) with 6 cycles or 12 cycles of epcoritamab in patients with relapsed or refractory chronic lymphocytic leukemia or Small Lymphocytic Lymphoma. AETHER study (ABT199 + Epcoritamab THErapy for Relapsed/refractory CLL/SLL)
Sponsor Stichting Hemato-Oncologie voor Volwassenen Nederland (Hovon)
- Start (EU)
- Latest update
- Estimated end
- Not reported
Danish non-inferiority study of ocrelizumab and rituximab in MS: A randomized study comparing the efficacy of ocrelizumab and rituximab in active multiple sclerosis
Sponsor Rigshospitalet
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart in Adults With Dermatomyositis
Sponsor Argenx
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Sanquin Blood Supply Foundation?
The 2026-10-09 snapshot links Sanquin Blood Supply Foundation to 5 distinct CTIS trials. Recorded services include Laboratory services, Provide product, Total C2 and CH50. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Sanquin Blood Supply Foundation?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Sanquin Blood Supply Foundation conducted?
The linked trials record locations in 16 countries, including Belgium, Germany, Spain, Italy, Denmark. These are trial locations, not confirmed office locations or countries where Sanquin Blood Supply Foundation delivered services.
What can this page tell me about Sanquin Blood Supply Foundation's trial experience?
Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Sanquin Blood Supply Foundation. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Sanquin Blood Supply Foundation